Strober, B., Papp, K. A., Flack, M., Gu, Y., Thompson, E. H. and Valdecantos, W. C. (2017) “Distribution of Improvements in Psoriasis Area and Severity Index from the Phase 2 Trial of Risankizumab in Moderate-to-Severe Plaque Psoriasis”, SKIN The Journal of Cutaneous Medicine, 1(3.1), p. s10. doi: 10.25251/skin.1.supp.9.